Sildenafil citrate (oral therapy)
This is an oral therapy that has a UK license for erectile dysfunction.
It is a phosphodiesterase 5 (PDE5) inhibitor which in turn enhances the effect of nitric oxide. Nitric oxide acts on enzymes which enable smooth-muscle relaxation in the corpus cavernosum, allowing an inflow of blood, and resulting in a penile erection.
Sildenafil citrate is contra-indicated in patients taking organic nitrates (1).
Reported side effects include flushing, headache, dyspepsia, nasal congestion, dizziness, diarrhoea, rashes and UTIs. There have been six reports of deaths (related to MIs) occurring in users of sildenafil citrate. It is unclear whether sildenafil citrate reacted with prescribed heart medication or the deaths were the result of unaccustomed sexual exertion.
Ref:Bandolier (1998), 5(7),1-4.
Related pages
- Interactions and contraindications
- Taking sildenafil
- Unwanted effects
- Comparisons with other therapies
- Male impotence
- Phosphodiesterase (PDE5) inhibitors in erectile dysfunction
- Comparison of onset and duration of action of different phosphodiesterase (PDE5) inhibitors
- Eligible groups for NHS funding for erectile dysfunction (ED)
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.